Bank of America
PRAX icon

Bank of America’s Praxis Precision Medicines PRAX Stock Holding History

Bank of America’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,000
Closed -$1.05M – 8606
2025
Q2 		$1.05M Hold
25,000
– – ﹤0.01% 5273
2025
Q1 		$947K Buy
+25,000
New +$1.56M ﹤0.01% 5263

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bank of America's PRAX Position: Q1 2026 in Review

Bank of America increased its Praxis Precision Medicines (PRAX) stake by 2.3% in Q1 2026, buying an estimated $3.66M and bringing the position to 534,604 shares worth $172M. The position accounts for 0.01% of the portfolio, ranked #806.

Bank of America first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Bank of America held 534,604 shares of Praxis Precision Medicines worth $172M as of Q1 2026.
  • Bank of America bought 11,841 Praxis Precision Medicines shares in Q1 2026, an estimated $3.66M.
  • Praxis Precision Medicines made up 0.01% of Bank of America's portfolio in Q1 2026, its #806 holding.
  • Bank of America first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.